Coronavirus (2019-nCoV)

Subterms

    More stories

    • 100 Shares129 Views

      in Elections

      New Report Underscores the Seriousness of Long Covid

      by

      The National Academies said the condition could involve up to 200 symptoms, make it difficult for people to work and last for months or years.One of the nation’s premier medical advisory organizations has weighed in on long Covid with a 265-page report that recognizes the seriousness and persistence of the condition for millions of Americans.More than four years since the start of the coronavirus pandemic, long Covid continues to damage many people’s ability to function, according to the National Academies of Sciences, Engineering and Medicine, a nongovernmental institution that advises federal agencies on science and medicine.“Long Covid can impact people across the life span, from children to older adults, as well as across sex, gender, racial, ethnic and other demographic groups,” it said, concluding that “long Covid is associated with a wide range of new or worsening health conditions and encompasses more than 200 symptoms involving nearly every organ system.”Here are some of the National Academies’ findings, drafted by a committee of 14 doctors and researchers:How many people have long Covid?The report cited data from 2022 suggesting that nearly 18 million adults and nearly a million children in the United States have had long Covid at some point. At the time of that survey, about 8.9 million adults and 362,000 children had the condition.Surveys showed that the prevalence of long Covid decreased in 2023 but, for unclear reasons, has risen this year. As of January, data showed nearly 7 percent of adults in the United States had long Covid.Diagnosis and consequencesThere is still no standardized way to diagnose the condition and no definitive treatments to cure it. “There is no one-size-fits-all approach to rehabilitation, and each individual will need a program tailored to their complex needs,” the National Academies said, advising that doctors should not require patients to have a positive coronavirus test to be diagnosed with long Covid.We are having trouble retrieving the article content.Please enable JavaScript in your browser settings.Thank you for your patience while we verify access. If you are in Reader mode please exit and log into your Times account, or subscribe for all of The Times.Thank you for your patience while we verify access.Already a subscriber? Log in.Want all of The Times? Subscribe. More

    • 113 Shares109 Views

      in Elections

      A Summer Guide to Covid Testing, Symptoms and Treatment

      by

      Experts say cases could rise in the coming weeks. Here’s what to know about symptoms, testing and treatment.As the so-called “FLiRT” variants of the coronavirus continue to gain traction, doctors and researchers are bracing for a potential rise in cases this summer. KP.2, one of these variants, now accounts for 28.5 percent of cases, and data from the Centers for Disease Control and Prevention shows a small increase in Covid-related emergency room visits and positive tests.Here’s what to know about symptoms, testing and treatment if you do fall ill:Symptoms to watch out forThere’s no evidence that symptoms of the FLiRT variants and other recent strains are any different, said Aubree Gordon, an infectious disease epidemiologist at the University of Michigan.The symptoms still include sneezing, congestion, headaches, sore muscles, nausea or vomiting. Many people also report exhaustion and a general “blah” feeling.In general, the more immunity you’ve built up from vaccination or past infections, the milder your next bout with the virus is likely to be. (Though it’s possible to experience more intense symptoms with a new infection than you’ve had in past Covid cases.)The symptoms of Covid can look similar to those caused by allergies or other infections. The best way to tell the difference is to test.When (and how) to testIn an ideal world, experts said, people would take a Covid test as soon as they develop symptoms or learn they were exposed, and then test again a day or two later. But if you only have a limited number of at-home rapid tests, there are a few ways to maximize their usefulness: Test immediately if you have a fever and a cough, said Dr. Davey Smith, an infectious disease specialist at the University of California, San Diego.We are having trouble retrieving the article content.Please enable JavaScript in your browser settings.Thank you for your patience while we verify access. If you are in Reader mode please exit and log into your Times account, or subscribe for all of The Times.Thank you for your patience while we verify access.Already a subscriber? Log in.Want all of The Times? Subscribe. More

    • 88 Shares149 Views

      in Elections

      The One Thing Voters Remember About Trump

      by

      What one thing do you remember most about Donald Trump’s presidency? In April as part of the New York Times/Siena College survey, we called about 1,000 voters across the country and asked for their most prominent memory of the Trump years. Here’s what they said, in their own words. “His honesty” Trump supporter in 2024 […] More

    • 150 Shares109 Views

      in Elections

      What to Know About New Covid Variants, ‘FLiRT’: Symptoms, Vaccines and More

      by

      Experts are closely watching KP.2, now the leading variant.For most of this year, the JN.1 variant of the coronavirus accounted for an overwhelming majority of Covid cases. But now, an offshoot variant called KP.2 is taking off. The variant, which made up just one percent of cases in the United States in mid-March, now makes up over a quarter.KP.2 belongs to a subset of Covid variants that scientists have cheekily nicknamed “FLiRT,” drawn from the letters in the names of their mutations. They are descendants of JN.1, and KP.2 is “very, very close” to JN.1, said Dr. David Ho, a virologist at Columbia University. But Dr. Ho has conducted early lab tests in cells that suggest that slight differences in KP.2’s spike protein might make it better at evading our immune defenses and slightly more infectious than JN.1.While cases currently don’t appear to be on the rise, researchers and physicians are closely watching whether the variant will drive a summer surge.“I don’t think anybody’s expecting things to change abruptly, necessarily,” said Dr. Marc Sala, co-director of the Northwestern Medicine Comprehensive Covid-19 Center in Chicago. But KP.2 will most likely “be our new norm,’” he said. Here’s what to know.The current spread of CovidExperts said it would take several weeks to see whether KP.2 might lead to a rise in Covid cases, and noted that we have only a limited understanding of how the virus is spreading. Since the public health emergency ended, there is less robust data available on cases, and doctors said fewer people were using Covid tests.But what we do know is reassuring: Despite the shift in variants, data from the C.D.C. suggests there are only “minimal” levels of the virus circulating in wastewater nationally, and emergency department visits and hospitalizations fell between early March and late April.We are having trouble retrieving the article content.Please enable JavaScript in your browser settings.Thank you for your patience while we verify access. If you are in Reader mode please exit and log into your Times account, or subscribe for all of The Times.Thank you for your patience while we verify access.Already a subscriber? Log in.Want all of The Times? Subscribe. More

    • 175 Shares199 Views

      in Elections

      Biotech Exec Gets 7 Years in Prison for False Claims About Rapid Covid-19 Test

      by

      Prosecutors said Keith Berman falsely claimed he had invented a blood test that could detect Covid-19 in 15 seconds. His lawyer said he had put “genuine effort” into developing such a test.The former chief executive of a biotechnology company who, during the early days of the pandemic, falsely claimed that he had invented a blood test that could detect Covid-19 in 15 seconds was sentenced on Friday to seven years in prison for securities fraud, federal prosecutors said.From February 2020 to December 2020, the former executive, Keith Berman, 70, of Westlake Village, Calif., engaged in a scheme to defraud people into investing in his company, Decision Diagnostics Corporation, by claiming the test could detect Covid using a finger prick sample of blood, prosecutors said.In March and April 2020, Mr. Berman issued 12 “false and misleading” news releases describing the rapid Covid test, which his company called GenViro, prosecutors wrote. Decision Diagnostics’ stock price jumped by more than 1,500 percent during the period, prosecutors said.In reality, prosecutors said, Mr. Berman had “privately confided in a friend the test could not actually detect Covid-19.”Prosecutors accused Mr. Berman, the sole director of the publicly traded medical device company, of capitalizing on people’s fears about the pandemic in an effort to resuscitate the company’s fortunes.Mr. Berman’s scheme resulted in about $28 million in investor losses, prosecutors said. Mr. Berman was indicted in December 2020, and he pleaded guilty in December 2023 to securities fraud, wire fraud and obstruction of an official proceeding.We are having trouble retrieving the article content.Please enable JavaScript in your browser settings.Thank you for your patience while we verify access. If you are in Reader mode please exit and log into your Times account, or subscribe for all of The Times.Thank you for your patience while we verify access.Already a subscriber? Log in.Want all of The Times? Subscribe. More

    • 125 Shares119 Views

      in Elections

      A Steadying Force for The Africa Center is Stepping Down

      by

      Uzodinma Iweala, chief executive of the Harlem institution, will leave at the end of 2024 after guiding it through pandemic years and securing funds.After guiding The Africa Center through rocky pandemic years and securing a huge chunk of funding for a major construction project, the leader of the Harlem institution is stepping down.Uzodinma Iweala, who is in his seventh year as chief executive of the Africa Center, will depart at the end of 2024.Iweala’s leadership helped to settle an institution with a tumultuous past of various mandates, locations and even names. It was formerly known as the Museum for African Art, which The New York Times’s co-chief art critic, Holland Cotter, called the “source of some of the most conceptually daring exhibitions of its era,” and before that, the Center for African Art. Faced with a delayed opening date during the pandemic, Iweala expanded its programming to include lectures and visits from heads of state, outdoor dance parties, films and author talks. All of it was aimed at connecting with the African diaspora and changing the way Americans interact with the African continent.Iweala, who as a writer and medical doctor has a nontraditional background for an arts institution leader, said he planned to focus on new creative projects including finishing a book. His multifaceted background and personal history — he is Nigerian-American and has lived in Nigeria — were regarded by many in the arts community as a good fit for an institution trying to transform itself into more than a museum or gallery. In an interview last year, the Studio Museum in Harlem’s Thelma Golden called him “visionary.”“I’m really proud of what we’ve been able to build over the past few years, especially in a challenging environment,” Iweala said. “It’s the right time to leave for me and for the institution.”Under Iweala, the Center has partnered with the Museum of Food and Drink on an exhibition as well as independent curators to offer “States of Becoming,” a 2022-23 exhibition that featured 17 African artists from the continent and diaspora. He partnered with the University of Cape Town to help organize a media index to track how Africa is covered in the media and created the Future Africa Forum that offered discussions with presidents, philanthropists and other leaders during the U.N. General Assembly meetings in New York.We are having trouble retrieving the article content.Please enable JavaScript in your browser settings.Thank you for your patience while we verify access. If you are in Reader mode please exit and log into your Times account, or subscribe for all of The Times.Thank you for your patience while we verify access.Already a subscriber? Log in.Want all of The Times? Subscribe. More

    • 175 Shares109 Views

      in Elections

      2 Ex-Officials at Veterans Home Where 76 Died in Covid Outbreak Avoid Jail Time

      by

      The former superintendent and medical director of the Holyoke Soldiers’ Home in Massachusetts were indicted in 2020 on charges of neglect after many residents became sick and died.Two former officials at a Massachusetts veterans’ home where at least 76 people died during a coronavirus outbreak in 2020 won’t have to serve any jail time under a court order imposed by a state judge on Tuesday, according to the Massachusetts Attorney General’s Office.The two — Bennett Walsh, the former superintendent at Holyoke Soldiers’ Home in Holyoke, Mass., and Dr. David Clinton, the former medical director there — were each indicted in September 2020 on five criminal counts of neglect, the attorney general’s office said.The charges were centered on a decision by the facility in March 2020 to consolidate two dementia units into one, which led to the “mingling” of residents who had contracted the coronavirus with others, the attorney general’s office said when the indictment was announced.The move to consolidate the units happened in the early days of the pandemic as many were just beginning to learn how the coronavirus spread. What followed was an outbreak that led to the deaths of at least 76 people at the facility.At a hearing on Tuesday afternoon at the Hampshire County Superior Court in Northampton, Mass., the attorney general’s office asked that Mr. Walsh and Dr. Clinton be sentenced to one year of home confinement, with three years of probation.Mr. Walsh and Dr. Clinton asked the court for a continuance without a finding, meaning that they would admit that there was enough evidence to find them guilty, according to the attorney general’s office.We are having trouble retrieving the article content.Please enable JavaScript in your browser settings.Thank you for your patience while we verify access. If you are in Reader mode please exit and log into your Times account, or subscribe for all of The Times.Thank you for your patience while we verify access.Already a subscriber? Log in.Want all of The Times? Subscribe. More

    • 138 Shares109 Views

      in Elections

      Large Grocers Took Advantage of Pandemic Supply Chain Disruptions, F.T.C. Finds

      by

      A report found that large firms pressured suppliers to favor them over competitors. It also concluded that some retailers “seem to have used rising costs as an opportunity to further hike prices.”Large grocery retailers took advantage of supply chain disruptions to beat out smaller rivals and protect their profits during the pandemic, according to a report released by the Federal Trade Commission on Thursday.The report found that some large firms “accelerated and distorted” the effects of supply chain snarls, including by pressuring suppliers to favor them over competitors. Food and beverage retailers also posted strong profits during the height of the pandemic and continue to do so today, casting doubt on assertions that higher grocery prices are simply moving in lock step with retailers’ own rising costs, the authors argued.“Some firms seem to have used rising costs as an opportunity to further hike prices to increase their profits, and profits remain elevated even as supply chain pressures have eased,” the report read.The report’s release comes as the F.T.C. cracks down on large grocery retailers. Last month, the commission and several state attorneys general sued to block Kroger from completing its $25 billion acquisition of the grocery chain Albertsons. They argued that the deal would weaken competition and likely lead to consumers paying higher costs.The independent federal agency’s actions have helped bolster the Biden administration’s efforts to address rising prices. In recent weeks, President Biden has taken a tougher stance on grocery chains, accusing them of overcharging shoppers and earning excess profits. Although food prices are now increasing at a slower rate, they surged rapidly in 2022 and have not fallen overall. As a result, the high cost of food has continued to strain many consumers and posed a political problem for the administration.Mr. Biden has also tried to tackle the issue by fixating on food companies, denouncing them for reducing the package sizes and portions of some products without lowering prices, a practice commonly called “shrinkflation.” During his State of the Union address earlier this month, Mr. Biden again called on snack companies to put a stop to the practice.We are having trouble retrieving the article content.Please enable JavaScript in your browser settings.Thank you for your patience while we verify access. If you are in Reader mode please exit and log into your Times account, or subscribe for all of The Times.Thank you for your patience while we verify access.Already a subscriber? Log in.Want all of The Times? Subscribe. More